Literature DB >> 31694958

A CD4+ T Cell-NK Cell Axis of Gammaherpesvirus Control.

Clara Lawler1, Philip G Stevenson2,3.   

Abstract

CD4+ T cells are essential to control herpesviruses. Murid herpesvirus 4 (MuHV-4)-driven lung disease in CD4+ T-cell-deficient mice provides a well-studied example. Protective CD4+ T cells have been hypothesized to kill infected cells directly. However, removing major histocompatibility complex class II (MHCII) from LysM+ or CD11c+ cells increased MuHV-4 replication not in those cells but in type 1 alveolar epithelial cells, which lack MHCII, LysM, or CD11c. Disruption of MHCII in infected cells had no effect. Therefore, CD4+ T cells engaged uninfected presenting cells and protected indirectly. Mice lacking MHCII in LysM+ or CD11c+ cells maintained systemic antiviral CD4+ T cell responses, but recruited fewer CD4+ T cells into infected lungs. NK cell infiltration was also reduced, and NK cell depletion normalized infection between MHCII-deficient and control mice. Therefore, NK cell recruitment seemed to be an important component of CD4+ T-cell-dependent protection. Disruption of viral CD8+ T cell evasion made this defense redundant, suggesting that it is important mainly to control CD8-evasive pathogens.IMPORTANCE Gammaherpesviruses are widespread and cause cancers. CD4+ T cells are a key defense. We found that they defend indirectly, engaging uninfected presenting cells and recruiting innate immune cells to attack infected targets. This segregation of CD4+ T cells from immediate contact with infection helps the immune system to cope with viral evasion. Priming this defense by vaccination offers a way to protect against gammaherpesvirus-induced cancers.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CD4 T cell; MHC class II; antiviral immunity; gammaherpesvirus; immune evasion

Year:  2020        PMID: 31694958      PMCID: PMC7000980          DOI: 10.1128/JVI.01545-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.

Authors:  P G Stevenson; J S May; X G Smith; S Marques; H Adler; U H Koszinowski; J P Simas; S Efstathiou
Journal:  Nat Immunol       Date:  2002-07-08       Impact factor: 25.606

2.  CD4+ T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation.

Authors:  Andreas J Müller; Orchidée Filipe-Santos; Gerard Eberl; Toni Aebischer; Gerald F Späth; Philippe Bousso
Journal:  Immunity       Date:  2012-06-21       Impact factor: 31.745

Review 3.  Cmv1 and natural killer cell responses to murine cytomegalovirus infection.

Authors:  A A Scalzo; W M Yokoyama
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 4.  The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection.

Authors:  Josef Mautner; Georg W Bornkamm
Journal:  Eur J Cell Biol       Date:  2011-04-01       Impact factor: 4.492

5.  Antibody-mediated control of persistent gamma-herpesvirus infection.

Authors:  In-Jeong Kim; Emilio Flaño; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

6.  Type I Interferon Signaling to Dendritic Cells Limits Murid Herpesvirus 4 Spread from the Olfactory Epithelium.

Authors:  Clara Lawler; Philip G Stevenson
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

7.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.

Authors:  Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng
Journal:  Nat Neurosci       Date:  2009-12-20       Impact factor: 24.884

8.  Expansion and activation of NK cell populations in a gammaherpesvirus infection.

Authors:  R C Thomson; J Petrik; A A Nash; B M Dutia
Journal:  Scand J Immunol       Date:  2008-03-18       Impact factor: 3.487

9.  Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Authors:  Tanzina Haque; Gwen M Wilkie; Marie M Jones; Craig D Higgins; Gillian Urquhart; Phoebe Wingate; David Burns; Karen McAulay; Marc Turner; Christopher Bellamy; Peter L Amlot; Deirdre Kelly; Alastair MacGilchrist; Maher K Gandhi; Anthony J Swerdlow; Dorothy H Crawford
Journal:  Blood       Date:  2007-04-27       Impact factor: 22.113

10.  Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages.

Authors:  Babunilayam Gangadharan; Marieke A Hoeve; Judith E Allen; Bahram Ebrahimi; Susan M Rhind; Bernadette M Dutia; Anthony A Nash
Journal:  J Leukoc Biol       Date:  2008-04-24       Impact factor: 4.962

View more
  2 in total

1.  CD4+ T Cells Control Murine Cytomegalovirus Infection Indirectly.

Authors:  Wanxiaojie Xie; Byungchul Lee; Kimberley Bruce; Clara Lawler; Helen E Farrell; Philip G Stevenson
Journal:  J Virol       Date:  2022-03-16       Impact factor: 6.549

2.  Conquering the Host: Determinants of Pathogenesis Learned from Murine Gammaherpesvirus 68.

Authors:  Yiping Wang; Scott A Tibbetts; Laurie T Krug
Journal:  Annu Rev Virol       Date:  2021-09-29       Impact factor: 14.263

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.